Liu, Keibun
Shibata, Junichiro
Fukuchi, Kiyoyasu
Takahashi, Kunihiko
Sonoo, Tomohiro
Ogura, Takayuki
Goto, Tadahiro
Article History
Received: 11 January 2022
Accepted: 11 April 2022
First Online: 25 April 2022
Declarations
:
: The study protocol was approved by the ethics committee of the Japan Red Cross Maebashi Hospital (No 27-17). The informed consent from the patient was waived in this study.
: Not applicable.
: Dr. Liu reports personal fees from MERA and is the core research members of TXP Medical Co., Ltd completely outside the submitted work. Dr. Sonoo is the Chief Executive Officer of TXP Medical Co. Ltd. and reports grants from AI Hospital Research grant from Japan Cabinet Office. Dr. Goto is the Chief Scientific Officer of TXP Medical Co., Ltd.